Colistimethate sodium (Coly-Mycin M) is an antibiotic used to treat infections caused by certain bacteria. It works by disrupting the bacterial cell membrane. It has potential side effects involving the central nervous system, gastrointestinal tract, genitourinary system, and musculoskeletal system. Nurses are responsible for administering the drug properly via various routes, monitoring for side effects like diarrhea, and notifying the prescriber of any issues. Due to the risk of kidney damage and drug interactions, the patient's renal function and other medications must be considered.
Colistimethate sodium (Coly-Mycin M) is an antibiotic used to treat infections caused by certain bacteria. It works by disrupting the bacterial cell membrane. It has potential side effects involving the central nervous system, gastrointestinal tract, genitourinary system, and musculoskeletal system. Nurses are responsible for administering the drug properly via various routes, monitoring for side effects like diarrhea, and notifying the prescriber of any issues. Due to the risk of kidney damage and drug interactions, the patient's renal function and other medications must be considered.
Colistimethate sodium (Coly-Mycin M) is an antibiotic used to treat infections caused by certain bacteria. It works by disrupting the bacterial cell membrane. It has potential side effects involving the central nervous system, gastrointestinal tract, genitourinary system, and musculoskeletal system. Nurses are responsible for administering the drug properly via various routes, monitoring for side effects like diarrhea, and notifying the prescriber of any issues. Due to the risk of kidney damage and drug interactions, the patient's renal function and other medications must be considered.
Colistimethate sodium (Coly-Mycin M) is an antibiotic used to treat infections caused by certain bacteria. It works by disrupting the bacterial cell membrane. It has potential side effects involving the central nervous system, gastrointestinal tract, genitourinary system, and musculoskeletal system. Nurses are responsible for administering the drug properly via various routes, monitoring for side effects like diarrhea, and notifying the prescriber of any issues. Due to the risk of kidney damage and drug interactions, the patient's renal function and other medications must be considered.
Name of Drug Classification Indication Contraindication Side Effects Nursing Responsibilities
Action Generic Name: Pharmacologic Penetrates into and General Hypersensitivity to CNS: Dizziness, Before Colistimethate Sodium Class: disrupts bacterial Indications: colistimethate or its fever, paresthesia, -Wash hands before administration of medication. Polypeptide cell membrane, To treat acute or components, renal slurred speech, -Check the doctor’s order. Trade/Brand Name: resulting in cell chronic gram- disease tingling of -Verify pt’s identification. Coly-Mycin M death. negative Drug to Drug extremities, -Use colistimethate cautiously in patients with impaired Colistimethate is an infections caused Interactions: vertigo renal function. Patients’ Dose----------- inactive prodrug of by Enterobacter aminoglycosides, GI: Nausea, - Caution patient to avoid performing hazardous the bioactive form aerogenes, vancomycin: pseudomembrano activities, including driving, during colistimethate Route: IM injection, IV colistin. Colistin Escherichia coli, Increased risk of us colitis, therapy. injection, IV infusion, Therapeutic binds to gram- Klebsiella developing vomiting - Explain need for frequent blood tests during therapy to inhalation Class: negative bacterial pneumoniae, and nephrotoxicity GU: Decreased check kidney function. Antibiotic cell membrane Pseudomonas curaniform muscle creatinine - Remind patient that watery or bloody stools can occur Form: Parenteral, phospholipids, aeruginosa relaxants, such as clearance and 2 or more months after antibiotic therapy and can be capsule increasing cell tubocurarine, urine output, serious, requiring prompt treatment. Pregnancy membrane decamethonium, increased BUN - Before giving drug I.M., make sure dose is appropriate Maximum dose: Category C permeability and ether, gallamine, and serum for degree of renal function. IM/IV: causing loss of succinylcholine: creatinine, Adult metabolites Potentiated nephrotoxicity During ≤60 kg: 75,000 essential to Patient’s neuromuscular MS: Muscle -Reconstitute each 150-mg vial with 2 ml sterile water IU/kg/day bacterial existence. Indication: blocking effect of weakness for injection to yield 75 mg/ml. During reconstitution, >60 kg: 6 MIU/24 hr --------------------- these drugs sodium RESP: Apnea, swirl vial gently to avoid frothing. INHALATION: cephalothin: Possibly respiratory -When giving by I.V. injection, slowly inject half of 6 MIU/day enhanced distress total daily dose over 3 to 5 minutes and repeat dose 12 Pharmacokinetics: nephrotoxicity SKIN: Pruritus, hours later, as ordered. Minimum dose: Absorption: Time rash, urticaria -When giving by I.V. infusion, slowly inject half of total IM/IV Source: to peak plasma Source: daily dose over 3 to 5 minutes. Adult MIMS.(2020). concentration: 2-3 MIMS.(2020). ----Then add remaining half of total daily dose to an ≤60 kg: 50,000 Colistimethate hr (IM). Colistimethate appropriate solution, such as normal saline solution or IU/kg/day in 3 divided sodium: Distribution: Wide sodium: Source: Source: D5W, with type and amount of solution dictated by doses. Indication, ly distributed, Indication, MIMS.(2020). MIMS.(2020). patient’s fluid and electrolyte needs. >60kg: 1-2 MIU tid. Dosage, Side except in CNS and Dosage, Colistimethate Colistimethate -----Starting 1 to 2 hours after first dose, slowly infuse INHALATION: Effect, in synovial, pleural, Side Effect, sodium: Indication, sodium: remaining drug over 22 to 23 hours. If patient has renal 1-2 MIU bid or tid Precaution and pericardial Precaution Dosage, Side Effect, Indication, impairment, use a reduced infusion rate. Once the Retrieved 21 fluids; crosses Retrieved 21 Precaution. Retrieved Dosage, Side infusion is prepared, use within 24 hours. March 2020, placenta and enters March 2020, from 21 March 2020, from Effect, Precaution Availability: from breast milk. Plasma https://www.mims https://www.mims.co Retrieved 21 After Coly-mycin m 150 mg https://www. protein binding: .com/philippines/ m/philippines/drug/in March 2020, from -Notify prescriber if patient develops neurologic changes vial mims.com/ 50%. drug/info/colistim fo/colistimethate%2 https://www.mims (paresthesia, tingling of limbs, pruritus, vertigo, Colistimethate 150 mg philippines/drug/ Metabolism: Unde ethate 0sodium/?type=brief .com/philippines/ dizziness, vial info/ rgoes hydrolysis to %20sodium/? &mtype=generic. drug/info/colistim slurred speech). Dosage may need to be reduced. Coly-Mycin S 3.3-3-10 colistimethate%2 the active substance type=brief&mtyp ethate - Monitor patient receiving drug I.M. because apnea and mg/ml Suspension 5ml 0sodium/? colistin. e=generic. Jones & Bartlett %20sodium/? neuromuscular blockade may Bottle type=brief Excretion: Mainly (2015). Nurses’ Drug type=brief&mtyp occur with this route, especially in patients with colistimethate For &mtype=generic via urine, as Jones & Bartlett Handbook. 14th Ed. e=generic. impaired renal function. Injection 150 mg/vial unchanged drug. (2015). Nurses’ Burlington, MA -Monitor patient’s bowel elimination. If diarrhea Jones & Bartlett Elimination half- Drug Handbook. Jones & Bartlett develops, obtain stool culture tocheck for Content: (2015). Nurses’ life: 2-3 hr. 14th Ed. (2015). Nurses’ pseudomembranous colitis. If Colistimethate Sodium Drug Handbook. Burlington, MA Drug Handbook. confirmed, expect to stop drug and give fluid, Active Moieties: 14th Ed. Source: 14th Ed. electrolytes, and antibiotics effective Colistin Burlington, MA MIMS. (2020). Burlington, MA against Clostridium difficile. Colistimethate Source: sodium: Source: Jones & Bartlett (2015). Indication, Dosage, MIMS.(2020). Nurses’ Drug Side Effect, Colistimethate sodium: Indication, Dosage, Side Effect, Handbook. 14th Ed. Precaution. Precaution. Retrieved 21 March 2020, from Burlington, MA Retrieved 21 March https://www.mims.com/philippines/drug/info/colistimeth 2020, from ate%20sodium/?type=brief&mtype=generic. MIMS. https://www.mims.c (2020). Colistimethate om/philippines/drug Jones & Bartlett (2015). Nurses’ Drug Handbook. 14th sodium: Indication, /info/colistimethate Ed. Burlington, MA Dosage, Side Effect, %20sodium/? Precaution. Retrieved type=brief&mtype= 21 generic. March 2020, from https://www.mims.com/ Jones & Bartlett philippines/drug/info/ (2015). Nurses’ colistimethate%2 Drug Handbook. 0sodium/?type=brief 14th Ed. Burlington, &mtype=generic. MA